coprd-ksu.com
About US
Contact US
Home
Committee & Teams
Participations
Program
Awards
Book
Submission Guidelines
COPRD Memories
Partners
Abbvie
AJA Pharma
Register
Register
Home
Committee & Teams
Participations
Program
Awards
Book
Submission Guidelines
COPRD Memories
Partners
Abbvie
AJA Pharma
Experimental Therapeutics and Toxicology
Home
Experimental Therapeutics and Toxicology
Angiotensin-II type 1 Receptor Blockade Prevents Tivozanib-induced Hypertension and Renal-cardiovascular Toxicity
Oxytocin Protects PC12 Cells Against β-Amyloid-Induced Cell Injury
Investigating the Effects of Combining Inorganic Nanoparticles with Doxorubicin on Human Breast Cancer MCF-7 Cells
Molecular Toxicity of Electronic Cigarettes on A549 Lung Cells and Their Effects on Key Pathways of Metabolomics
Senolytics: Novel Therapeutic Agents To Target Chemotherapy-Induced Senescence in Breast Cancer Cell Lines
IL-17/Notch1/STAT3 contributes to 5-fluorouracil-induced intestinal mucositis in rats: Amelioration by Thymol treatment
Engineered Nanomaterial-based Combinations with Conventional Antibiotics against Clinically Isolated, Multi-drug Resistant Bacteria from Saudi Arabia Hospitals
Investigating the Behavioral and Neuronal Consequences of Prenatal Exposure to Electronic Cigarettes (E-Cigarettes) Vapor-Containing Nicotine in Adolescent Mice Brain
